252 related articles for article (PubMed ID: 36800183)
21. Differences in presentation, treatment, and outcomes among minority head and neck cancer patient groups in Los Angeles County.
Lin ME; Castellanos CX; Bagrodia N; West JD; Kokot NC
Am J Otolaryngol; 2024; 45(1):104031. PubMed ID: 37639986
[TBL] [Abstract][Full Text] [Related]
22. Social Determinants of Health and Geographic Variation in Medicare per Beneficiary Spending.
Zhang Y; Li J; Yu J; Braun RT; Casalino LP
JAMA Netw Open; 2021 Jun; 4(6):e2113212. PubMed ID: 34110394
[TBL] [Abstract][Full Text] [Related]
23. Geographic Barriers Affect Follow-Up Care in Head and Neck Cancer.
Alwani T; Shehan JN; LeClair J; Mahoney TF; Agarwal P; Chaudhry ST; Wang JJ; Noordzij JP; Tracy LF; Edwards HA; Grillone G; Salama AR; Jalisi SM; Devaiah AK
Laryngoscope; 2022 May; 132(5):1022-1028. PubMed ID: 34762300
[TBL] [Abstract][Full Text] [Related]
24. Insurance status, stage of presentation, and survival among female patients with head and neck cancer.
Panth N; Simpson MC; Sethi RKV; Varvares MA; Osazuwa-Peters N
Laryngoscope; 2020 Feb; 130(2):385-391. PubMed ID: 30900256
[TBL] [Abstract][Full Text] [Related]
25. Rising incidence of late-stage head and neck cancer in the United States.
Thompson-Harvey A; Yetukuri M; Hansen AR; Simpson MC; Adjei Boakye E; Varvares MA; Osazuwa-Peters N
Cancer; 2020 Mar; 126(5):1090-1101. PubMed ID: 31722124
[TBL] [Abstract][Full Text] [Related]
26. Community socioeconomic status and rural/racial disparities in HPV-/+ head and neck cancer.
Semprini J; Williams JC
Tech Innov Patient Support Radiat Oncol; 2023 Jun; 26():100205. PubMed ID: 36974082
[TBL] [Abstract][Full Text] [Related]
27. Delay of Surgery for Melanoma Among Medicare Beneficiaries.
Lott JP; Narayan D; Soulos PR; Aminawung J; Gross CP
JAMA Dermatol; 2015 Jul; 151(7):731-41. PubMed ID: 25853865
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of Social Determinants of Health and Prostate Cancer Outcomes Among Black and White Patients: A Systematic Review and Meta-analysis.
Vince RA; Jiang R; Bank M; Quarles J; Patel M; Sun Y; Hartman H; Zaorsky NG; Jia A; Shoag J; Dess RT; Mahal BA; Stensland K; Eyrich NW; Seymore M; Takele R; Morgan TM; Schipper M; Spratt DE
JAMA Netw Open; 2023 Jan; 6(1):e2250416. PubMed ID: 36630135
[TBL] [Abstract][Full Text] [Related]
29. Treatment patterns and survival among low-income medicaid patients with head and neck cancer.
Subramanian S; Chen A
JAMA Otolaryngol Head Neck Surg; 2013 May; 139(5):489-95. PubMed ID: 23598992
[TBL] [Abstract][Full Text] [Related]
30. Influence of Social Vulnerability in Treatment and Prognosis of Squamous Cell Carcinoma of the Tongue.
Fei-Zhang DJ; Park AC; Chelius DC; Smith SS; Samant S; Patel UA; Sheyn AM; Rastatter JC
Otolaryngol Head Neck Surg; 2024 May; 170(5):1338-1348. PubMed ID: 38353303
[TBL] [Abstract][Full Text] [Related]
31. Development and Validation of a County-Level Social Determinants of Health Risk Assessment Tool for Cardiovascular Disease.
Hong YR; Mainous AG
Ann Fam Med; 2020 Jul; 18(4):318-325. PubMed ID: 32661032
[TBL] [Abstract][Full Text] [Related]
32. Association Between Social Vulnerability Index and Cardiovascular Disease: A Behavioral Risk Factor Surveillance System Study.
Jain V; Al Rifai M; Khan SU; Kalra A; Rodriguez F; Samad Z; Pokharel Y; Misra A; Sperling LS; Rana JS; Ullah W; Medhekar A; Virani SS
J Am Heart Assoc; 2022 Aug; 11(15):e024414. PubMed ID: 35904206
[TBL] [Abstract][Full Text] [Related]
33. Epidemiological Trends of Head and Neck Cancer in the United States: A SEER Population Study.
Mourad M; Jetmore T; Jategaonkar AA; Moubayed S; Moshier E; Urken ML
J Oral Maxillofac Surg; 2017 Dec; 75(12):2562-2572. PubMed ID: 28618252
[TBL] [Abstract][Full Text] [Related]
34. Costs Associated With Imaging Surveillance After Treatment for Head and Neck Cancer.
Nocon CC; Kennedy A; Jaffe J; Pruitt J; Kuchta K; Bhayani MK
JAMA Otolaryngol Head Neck Surg; 2021 Jul; 147(7):632-637. PubMed ID: 33983375
[TBL] [Abstract][Full Text] [Related]
35. Minority Health Social Vulnerability Index and COVID-19 vaccination coverage - The United States, December 14, 2020-January 31, 2022.
Saelee R; Chandra Murthy N; Patel Murthy B; Zell E; Shaw L; Gibbs-Scharf L; Harris L; Shaw KM
Vaccine; 2023 Mar; 41(12):1943-1950. PubMed ID: 36797098
[TBL] [Abstract][Full Text] [Related]
36. Elderly Black Non-Hispanic Patients With Head and Neck Squamous Cell Cancer Have the Worst Survival Outcomes.
McDermott JD; Eguchi M; Morgan R; Amini A; Goddard JA; Borrayo EA; Karam SD
J Natl Compr Canc Netw; 2020 Sep; 19(1):57-67. PubMed ID: 32987364
[TBL] [Abstract][Full Text] [Related]
37. Chronic Sinusitis and Risk of Head and Neck Cancer in the US Elderly Population.
Beachler DC; Engels EA
JAMA Otolaryngol Head Neck Surg; 2017 Jan; 143(1):25-31. PubMed ID: 27606895
[TBL] [Abstract][Full Text] [Related]
38. Variations in Quality of Care by Sex and Social Determinants of Health Among Younger Adults With Acute Myocardial Infarction in the US and Canada.
Raparelli V; Pilote L; Dang B; Behlouli H; Dziura JD; Bueno H; D'Onofrio G; Krumholz HM; Dreyer RP
JAMA Netw Open; 2021 Oct; 4(10):e2128182. PubMed ID: 34668947
[TBL] [Abstract][Full Text] [Related]
39. Quantifying Total and Out-of-Pocket Costs Associated With Head and Neck Cancer Survivorship.
Massa ST; Chidambaram S; Luong P; Graboyes EM; Mazul AL
JAMA Otolaryngol Head Neck Surg; 2022 Dec; 148(12):1111-1119. PubMed ID: 36264567
[TBL] [Abstract][Full Text] [Related]
40. Adherence to Guideline-Concordant Care and Its Effect on Survival in Black Patients with Head and Neck Cancers: A SEER-Medicare Analysis.
Vyfhuis MAL; Suzuki I; Bentzen SM; Cullen KJ; Goloubeva OG
Oncologist; 2021 Jul; 26(7):579-587. PubMed ID: 33783061
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
